NICE recommends MRI for suspected prostate cancer to reduce biopsies
BMJ 2018; 363 doi: https://doi.org/10.1136/bmj.k5290 (Published 13 December 2018) Cite this as: BMJ 2018;363:k5290- Jacqui Wise
- London
Men with suspected prostate cancer should be offered multi-parametric magnetic resonance imaging (mpMRI) to reduce the number of invasive and unnecessary biopsies, says draft guidance from the UK National Institute for Health and Care Excellence.1 The technology produces a detailed image of the prostate that will help clinicians decide whether a biopsy or subsequent treatment is needed.
Many hospitals already offer mpMRI, but a freedom of information request carried out for the charity Prostate Cancer UK earlier this year found that only half of men with suspected prostate cancer were being offered the scan before biopsy.
Currently, men with suspected prostate cancer are offered a blood test to look for raised concentrations of prostate specific …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.